Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03739827 · ClinicalTrials.gov registry record

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

A clinical trial of Solid Tumor and Pediatric Solid Tumor, sponsored by National Cancer Institute (NCI).

Recruiting
Registry status
10,000
Enrollment target
3
Study locations

NCT03739827 is a study of Solid Tumor and Pediatric Solid Tumor that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 10,000 participants, above the 171-participant average among 196 other Solid Tumor trials with a reported enrollment target (5748% higher). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03739827, a study of Solid Tumor and Pediatric Solid Tumor, is actively recruiting participants, sponsored by National Cancer Institute (NCI).

RECRUITING
Registry status
10,000 participants
Enrollment target
3
Study locations

Study Summary

Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with rare tumors in order to learn more about how these tumors develop. The information obtained from this study may lead to improved screening, preventive guidelines, and treatments. Objective: To better understand rare cancers and hereditary cancer syndromes. Eligibility: People who have a rare tumor, a family history of a rare tumor, a hereditary cancer syndrome, or a mutation that leads to rare tumors. Design: Participants will be screened with questions about their medical history and/or that of their family members. They will give a saliva sample. Participants who have a tumor will have their medical records and tests reviewed. They will answer questions about their wellbeing and needs. They may provide a tumor tissue sample. Participants may also have: * Physical exam * Clinical photography * Blood, urine, saliva, and stool samples taken * Consultation with specialists * A scan that produces a picture of the body. Either one that uses a small amount of radiation, or one that uses a magnetic field. * Genetic testing/genetic counseling. Participants will be contacted once a year. They will answer updated questions about their medical and family history. Participants will be asked to contact the study team if there are changes in their tumors. Participants may be invited to join focus groups for people with the same diagnosis of rare tumors. Participants may be invited to participate in other NIH protocols. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* RARE TUMOR LIST: 1. Acinar cell carcinoma of the pancreas 2. Adamantinoma 3. Adenosqaumous carcinoma of the pancr

Conditions Studied

Solid Tumor Pediatric Solid Tumor Refractory Solid Tumors Malignant Solid Tumors Other Neoplasms Solid Tumors

Study Locations (3)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Oregon

  • Oregon Health and Science University - Portland

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 10,000 participants
Start Date 2019-01-28
Est. Completion 2032-03-31

Sponsor

National Cancer Institute (NCI)

3,257 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03739827

The ClinicalTrials.gov registry entry for NCT03739827 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 171-participant average among 196 other Solid Tumor trials with a reported enrollment target (5748% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Solid Tumor appearing as the primary indexed condition, and to 0 interventions.

NCT03739827 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Maryland, Oregon, Texas.

Frequently Asked Questions

What is clinical trial NCT03739827 about?

NCT03739827 is a clinical study titled "Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors". Background: Approximately 150 cases of cancer per one million per year are considered rare cancers. While all tumors originate from genetic changes, a small percentage of these tumors are familial. Researchers want to study these changes in biological samples from people with rare tumors in order t...

What is the current status of trial NCT03739827?

This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2019-01-28. Estimated completion is 2032-03-31.

What conditions does trial NCT03739827 study?

This clinical trial studies the following conditions: Solid Tumor, Pediatric Solid Tumor, Refractory Solid Tumors, Malignant Solid Tumors, Other Neoplasms Solid Tumors.

Who is sponsoring clinical trial NCT03739827?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03739827 being conducted?

This trial has 3 study locations across Maryland, Oregon, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Solid Tumor

All registered trials for this condition

Pediatric Solid Tumor

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.